Patent 7556803 was granted and assigned to Immune System Therapeutics on July, 2009 by the United States Patent and Trademark Office.
The present invention relates to methods for the treatment of multiple myeloma. More particularly, the present invention relates to a method for inducing apoptosis in myeloma cells by administration of a K121-like antibody.